5-Fluorouracil (5-Fu) in the treatment of prostatic hyperplasia.
A prospective study of 5-Fu in the treatment of prostatic hyperplasia was commenced in 1981. The short term results were fair in 70% of 43 patients. Atrophy of the glandular tissue could be observed on histopathologic examination. The study showed that the larger the glandular component the better was the therapeutic effect. If abundant fibromuscular tissue was present in the gland the treatment was unsatisfactory. Abnormal anatomy of the bladder neck, represented a contraindication to medical treatment.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D012008:Recurrence; D014549:Urinary Incontinence / Q000209:etiology
D005472:Fluorouracil